ACRP | DCTs: Key Considerations for Small-to-Midsized Biotechnology and Biopharmaceutical Companies
Decentralized clinical trials (DCTs) are no fad; they are entrenched in the future of clinical development.
Subscribe to Our Blog. Stay up to date with the latest news and insights.
Decentralized clinical trials (DCTs) are no fad; they are entrenched in the future of clinical development.
DCTs can be a great tool for small-to-midsize pharma and biotech companies despite misconceptions of them being advantageous for only Big Pharma.